Association and risk prediction of 19 complex diseases with polygenic scores and socioeconomic status

Fiona A. Hagenbeek(Public Health Service of Amsterdam), Veli-Matti Kosma(University of Eastern Finland), Tuomo Hartonen(University of Helsinki), Max Tamlander(University of Helsinki), Sanna Siltanen, Anne Richmond(Edinburgh Cancer Research), J. Maranville, Anna Vlahiotis, Tomi P. Mäkelä(University of Helsinki), Melis A. Aksit, Zhiyu Yang(University of Helsinki), Bridget Riley-Gills, Taneli Raivio(University of Helsinki), Kira E. Detrois(University of Helsinki), Slavé Petrovski(AstraZeneca (United Kingdom)), Minna Ruddock, Lila Kallio, Eero Punkka, Jörg Blankenstein(Maze (United States)), Howard Jacob(AbbVie (United States)), Antti Hakanen, Emily Holzinger, Jonathan Davitte(GlaxoSmithKline (United States)), Chris O´Donnell, FinnGen, Terhi Kilpi, Ellen Tsai(Biogen (United States)), Dawn Waterworth(Johnson & Johnson (United States)), Rion Pendergrass, Robert Plenge, Jukka Partanen(University of Helsinki), Mark McCarthy, Jaakko Kaprio(University of Helsinki), Aarno Palotie(Broad Institute), Katherine Klinger, Mark Daly(Broad Institute), Clement Chatelain, Kati Kristiansson(Tampere University), Markus Perola(Finnish Institute for Health and Welfare), Coralie Viollet(AstraZeneca (United Kingdom)), Teija Kekonen(Northern Ostrobothnia Hospital District), Nicole Renaud(Novartis (United States)), Robert Graham(Maze (United States)), Chia-Yen Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhihao Ding(Boehringer Ingelheim (Germany)), Daniel L. McCartney(Edinburgh Cancer Research), Raisa Serpi, Karol Estrada(Erasmus MC), Santha Ramakrishnan, Alix Berton
Communications Medicine
June 11, 2026
Cited by 0


Related Papers